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Abstract
Fructose-rich diets (FRD) cause cardiac insulin resistance manifested by impairment of Akt/endothelial NO synthase (eNOS) signalling. In
contrast, oestradiol (E2) activates this signalling pathway in the heart. To study the ability of E2 to revert the detrimental effect of fructose
on cardiac Akt/eNOS, female rats were subjected to a FRD and ovariectomy followed with or without E2 replacement. We also analysed the
effects of the FRD and E2 on cardiac extracellular signal-regulated kinase (Erk 1/2) signalling related to their role in cardiac hypertrophy
development. Expression of Akt, eNOS and Erk 1/2, as well as regulatory phosphorylations of these molecules were determined. The pro-
tein expression of cardiac Akt and eNOS was not affected by the diet or E2 treatment. However, the FRD was accompanied by a decrease in
Akt phosphorylation at Ser473 and Thr308, and eNOS at Ser1177, while the phosphorylation of eNOS at Thr495 was increased. E2 replacement
in ovariectomised fructose-fed rats caused a reversion of the diet effect on Akt and eNOS serine phosphorylation, but mostly had no effect
on threonine phosphorylation of the molecules. The FRD and E2 treatment did not influence Erk 1/2 expression and phosphorylation and
heart mass as well. The data show that E2 selectively suppress the negative effects of a FRD on Akt/eNOS signalling and probably point to
the different effects of E2 on kinase/phosphatase pathways responsible for phosphorylation/dephosphorylation of Akt and eNOS. Further-
more, the results suggest that the heart of females in the reproductive period is partially protected against the damaging effects of increased
fructose intake.
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Increased intake of fructose causes dramatic metabolic dis-
turbances leading to the development of insulin resistance,
type 2 diabetes and the metabolic syndrome in humans and
the animals(1,2). Although the genesis of fructose-induced
disorders is very complex and includes different tissues such
as hepatic, adipose, etc., cardiac events are also observed(3,4).
As has recently been reported, among other disturbances, a
fructose-rich diet (FRD) is accompanied by cardiac insulin
resistance that targets Akt/endothelial NO synthase (eNOS)
signalling(5,6). Consequences of enhanced fructose intake are
shown to be sex-dependent and the protective effect observed
in females is referred to oestrogens(7). It is well known that
oestrogens are important regulators of cardiac function and
the effects of physiological concentrations of oestrogens are
beneficial for the heart(8,9).
The phosphatidylinositol 3 kinase/Akt signalling pathway
regulating eNOS activity and eNOS itself is very important
for cardiac physiology(10–12). To be more interesting, Akt
and eNOS are also attributed to female-specific cardiac protec-
tion(13,14), and they have been shown to be activated in the
heart by oestrogens(15,16) in a rapid non-genomic way(17).
Moreover, the phosphatidylinositol 3 kinase/Akt/eNOS axis
is a backbone of insulin beneficial cardiac effects and a
target of cardiac insulin resistance(18). Activation of the Akt/
eNOS signalling pathway by insulin or otherwise requires
the phosphorylation of Akt at serine 473 and threonine 308
positions(19), as well as the phosphorylation of eNOS at
serine 1177 and dephosphorylation at threonine 495(20).
In addition, there are no data that a FRD influences cardiac
extracellular signal-regulated kinase (Erk 1/2) signalling(6).
However, an increased intake of fructose is blamed to be an
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inducer of heart hypertrophy development(21–23). In contrast,
oestradiol (E2) has the ability to activate cardiac mitogenic
Erk 1/2 signalling(24,25) and to prevent cardiac hypertrophy
in different pathological conditions(26,27).
On the basis of existing literature data indicating the detri-
mental effects of a FRD on cardiac Akt/eNOS signalling, as
well as the crucial importance of the same pathway for oestro-
gen signalling in the heart, we hypothesised that E2 might
attenuate cardiac disturbances related to an enhanced intake
of fructose. We also analysed the effects of a FRD and E2
replacement on cardiac Erk 1/2 signalling related to their
role in cardiac hypertrophy development. To validate our
hypothesis, we analysed Akt, eNOS and Erk 1/2 expression
and phosphorylation in the heart of ovariectomised female
rats subjected to a FRD in the absence and presence of E2.
Experimental methods
Chemicals
Fructose was purchased from API-PEK (Becej). Anti-phospho-
Ser473 Akt, anti-phospho-Thr308 Akt, anti-phospho-Ser1177
eNOS, anti-phospho-Thr495 eNOS, anti-actin and secondary
anti-mouse antibody were obtained from Santa Cruz Biotech-
nology, Inc. Anti-Akt antibody was purchased from Affinity
Bioreagents, Inc. Anti-eNOS antibody, anti-Erk 1/2 and anti-
phospho-Thr202/Tyr204 Erk 1/2 were products of Cell Signal-
ing. Reagents for the bicinchoninic acid assay were purchased
from Pierce. Secondary anti-rabbit and anti-goat antibodies,
insulin and 17b-E2 were purchased from Sigma-Aldrich
Corporation.
Animals
Animal experiments were conducted in accordance with
standards approved by the official Vinca Institute’s Ethical
Committee for Experimental Animals.
Female Wistar rats (21 d old) were separated from their
mothers and divided into the control (normal diet; ND)
group and FRD group. The control animals had free access
to tap water and standard laboratory chow. The animals on
the FRD were fed by the same food, but instead of tap
water they drank 10 % (w/v) fructose solution. The body
weight of rats in the two experimental groups was the same
at the beginning of the diet. All animals were kept under stan-
dard temperature and dark–light conditions. The diet regimen
prolonged for 9 weeks. Body mass was recorded during
the diet regimen, while mass of the heart was measured
after killing.
At 2 weeks before killing, all animals were bilaterally
ovariectomised, under ketamine (40 mg/kg, intraperi-
toneally)–xylazine (5 mg/kg, intraperitoneally) anaesthesia,
to remove endogenous oestrogens and to prevent their
effects(28). Then, half of the fructose-fed rats (FFR) were
subjected to E2 replacement treatment (40mg/kg, subcu-
taneously, every second day) after ovariectomy (OVX),
which continued until the day before killing. To study the
fructose and E2 effects on the insulin regulation of the
analysed molecules, the experimental groups were divided
into two subgroups, one of which was treated with insulin
(12 IU/kg of body weight, 40 min before killing, intraperito-
neally). Each group contained nine animals in three indepen-
dent experiments.
The dose and the way of E2 administration were taken over
from the literature as a replacement protocol, in order to
achieve the concentration of E2 near physiological(29,30). The
dose and timing of insulin treatment were also estimated on
the basis of literature data, adjusted to intraperitoneal admin-
istration(31), and optimised to observe the peak of changes
in the phosphorylation of Akt, Erk and eNOS.
The ovariectomised FFR were compared with the ovari-
ectomised animals subjected to the normal diet to assess
the effect of the fructose diet. The FFR treated with E2 were
compared with the ovariectomised FFR to analyse the effect
of E2 in the context of the fructose diet, as well as with ovari-
ectomised rats on the normal diet, to estimate E2 capacity
to counteract to the expected detrimental effect of the FRD.
The equivalent comparisons were performed for insulin-
treated counterparts of all three groups.
Preparation of cardiac cell lysate
After killing, the heart of rats was removed from the body,
washed with cold saline, dried and measured, and the
tissue was homogenised on cold with an Ultra-turrax hom-
ogeniser in a buffer (pH 7·4) containing 10 mM-Tris, 150 mM-
NaCl, 1 mM-EDTA, 1 mM-ethylene glycol tetraacetic acid
(EGTA), 1 % Triton X-100, protease inhibitors and phospha-
tase inhibitors(32). The homogenates were centrifuged at
600 g for 20 min at 48C and the supernatants obtained were
ultracentrifuged for 60 min at 100 000g. Protein concentration
was determined by the bicinchoninic acid method(33) and
after boiling in Laemmli sample buffer, the supernatants
were used as cardiac cell lysate for Western blot analysis.
SDS–PAGE and Western blotting
Cardiac lysate proteins (50mg/lane) were separated on 7·5 %
or 10 % SDS–PAGE and transferred to polyvinylidene fluoride
membranes(34). The membranes were blocked with 5 %
bovine serum albumin and blotted with an antibody against
phospho-Akt, anti-phospho-eNOS or phospho-Erk 1/2. After
extensive washing, the membranes were incubated with the
appropriate secondary horseradish peroxidase-conjugated
antibody and used for subsequent detection with ECL
reagents. Thereafter, the membranes were stripped, washed
and reprobed with antibodies against Akt, eNOS or Erk,
respectively. To ensure that protein loading was equal in all
samples, the blots were stripped again and incubated with
actin antibody. Films were scanned and analysed using
ImageJ software (NIH).
RNA isolation and quantitative real-time RT-PCR
Immediately after removal, animal tissue was snap-frozen
in liquid N2 and then stored at 2708C. Total RNA was
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isolated with TRI Reagent (Ambion, Inc.) according to the
manufacturer’s instructions. The quantity of mRNA was
assessed by a NanoDropw ND-1000 spectrophotometer
(Thermo Scientific). Structural integrity of RNA was confirmed
by formaldehyde agarose gel electrophoresis. Total RNA from
the tissue specimens with satisfactory quality was converted to
complementary DNA. Then, 1mg of RNA was treated with
DNase I (Fermentas) and reverse transcription was performed
using a First Strand cDNA Synthesis Kit, with oligo-dT18
primers (Fermentas), according to the manufacturer’s instruc-
tions. Mock reactions lacking RT were performed during the
complementary DNA synthesis step in order to additionally
exclude genomic contamination. Real-time PCR was per-
formed in duplicate in an ABI Real-time 7500 System (ABI).
Detection of eNOS gene expression was done by amplification
in a total volume of 25 ml in EvaGreen qPCR Mastermix-R
(Applied Biological Materials, Inc.). Final concentrations of
primers were 6·25mmol/l each. The reaction conditions
were as follows: an initial denaturation at 958C for 10 min
followed by forty cycles of a denaturation step at 958C for
45 s, an annealing step at 608C for 60 s and an elongation
step at 728C for 60 s. All samples were normalised to the
housekeeping GAPDH transcript levels. Primer sequences of
GAPDH and eNOS genes are available upon request. Differ-
ences in mRNA expression between the groups were tested
by REST 09 software (Corbett Life Science).
Statistical analysis
Values are expressed as means and standard deviations
(except for mRNA expression results, where standard errors
were used instead of standard deviations). We performed
the same experiment three times independently and pooled
the results for all nine animals per group for one-way
ANOVA. A value of P,0·05 was considered as statistically
significant. The power analysis of the study was performed
by ‘PS power and sample size program’ software(35). The
power value for nine animals per group, with an observed
effect size and standard deviations and a significance level
of 0·05, was .0·8. In addition, differences in mRNA
expression between the groups were tested by a pairwise
randomisation and bootstrapping technique using the relative
expression software tool, REST 09 (Corbett Life Science,
http://rest.gene-quantification.info)(36).
Results
Mass of the heart of fructose-fed rats related to oestradiol
status
Based on the data that the FRD and the E2 treatment influence
the mass of the heart and are included in the genesis or
protection of heart hypertrophy, respectively, we measured
the mass of the heart and expressed it as an absolute value
or relative to the body mass. As presented in Fig. 1, neither
diet nor hormone replacement treatment altered the mass of
the heart (Fig. 1(a)) and the heart:body ratio (Fig. 1(b)).
Effects of the fructose-rich diet and oestradiol status on
the expression and phosphorylation of Akt in the heart of
ovariectomised female rats
Akt kinase is regulated by numerous phosphorylations of the
molecule, but those at positions Ser473 and Thr308 are assigned
as crucial for enzyme activity. As presented in Fig. 2(a) and (b),
the results of the present study confirmed that insulin
increases the phosphorylation of both residues. The FRD
decreased the phosphorylation of both amino acid residues
in the heart of rats, in basal conditions (with no additional
insulin treatment) and/or insulin-stimulated conditions
(P,0·001, OVX-FRD v. OVX-ND for Ser473; P,0·01, OVX-
FRD v. OVX-ND; P,0·05, OVX-FRD þ insulin v. OVX-ND þ
insulin for Thr308; Fig. 2(a) and (b)). The E2 treatment of
FFR reversed phospho-Ser473 Akt content to the control
level in basal conditions. However, E2 replacement was effec-
tive in reversing the diet effects on Akt phosphorylation at
Thr308 in insulin-stimulated conditions, while failed to reverse
the FRD effect in basal condition (P,0·01, OVX-FRD þ E2 v.
OVX-ND). Neither the diet nor hormone replacement changed
the protein expression of Akt in the heart (Fig. 2(c)), deter-
mined as Akt content in cardiac lysate.
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Fig. 1. (a) Absolute and (b) relative mass of the heart of fructose-fed rats:
the role of oestradiol. Mass of the heart was measured immediately after
killing and isolation from the body. It is expressed as an absolute value and
as a heart:body ratio. Values are means of three independent experiments
with nine animals per group, with standard deviations represented by vertical
bars. OVX, ovariectomy; ND, normal diet; FRD, fructose-rich diet; E2, oestra-
diol treatment. , OVX-ND; , OVX-FRD; , OVX-FRD þ E2.
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Expression and phosphorylation of the cardiac endothelial
nitric oxide synthase effects of the fructose-rich diet and
oestradiol replacement
Enzyme activity of eNOS is also regulated by a number of
serine/threonine phosphorylations. Phosphorylation at serine
1177 is accompanied by the activation of eNOS, while phos-
phorylation at threonine 495 is found to be constitutive and
inhibitory. Insulin itself stimulated phosphorylation at Ser1177
only (Fig. 3(a)). As presented in Fig. 3(a), a significant
decrease in Ser1177 phosphorylation of eNOS was observed
in the heart of FFR, in insulin-stimulated conditions (P,0·05,
OVX-FRD þ insulin v. OVX-ND þ insulin). E2 over-reverted
the negative effects of the fructose diet (P,0·05, OVX-
FRD þ E2 v. OVX-FRD; P,0·05, OVX-FRD þ E2 v. OVX-ND;
P,0·01, OVX-FRD þ E2 þ insulin v. OVX-FRD þ insulin;
P,0·05, OVX-FRD þ E2 þ insulin v. OVX-ND þ insulin) and
elevated the eNOS serine 1177 phosphorylation level above
the level detected in rats fed on the normal diet.
In contrast to the serine 1177 site, the FRD caused an
increase in the phosphorylation of eNOS at threonine 495 in
basal (P,0·001, OVX-FRD v. OVX-ND) and insulin-stimulated
conditions (P,0·05, OVX-ND þ insulin v. OVX-ND þ insulin)
(Fig. 3(b)). E2 replacement had no effect on this phosphoryl-
ation in FFR.
The protein content of eNOS determined in heart lysate was
unaffected by the FRD and did not depend on the presence
of E2 (Fig. 3(c)). In contrast to protein expression, as pre-
sented in Fig. 3(d), the steady-state mRNA level of eNOS was
surprisingly elevated in FFR (OVX-FRD v. OVX-ND,
expression mean factor 5·765, SE range 2·355–12·795, 95 %
CI 1·904, 19·051, P¼0·000). It is interesting to note that OVX
and the fructose diet separately acted as strong negative regu-
lators of cardiac eNOS mRNA expression (ovariectomised v.
intact rats, on the normal diet: mean factor 0·154, P¼0·018;
intact rats on the fructose diet v. intact rats on the normal
diet: mean factor 0·077, P¼0·016). In FFR, E2 replacement
returned the eNOS steady-state mRNA level to the control
value (OVX-FRD þ E2 v. OVX-ND, expression mean factor
0·995, SE range 0·290–3·144, 95 % CI 0·193, 4·620, P¼0·901).
Effects of the fructose-rich diet and oestradiol replacement
on the phosphorylation and expression of extracellular
signal-regulated kinase 1/2 in the heart of ovariectomised
female rats
The absence of the potential effects of the fructose diet and E2
treatment on heart mass initiated the analysis of their effects
on mitogenic signalling through Erk 1/2 kinases. In accord-
ance with the results obtained for the absolute and relative
mass of the heart, we did not observe any changes in Erk 1/
2 phosphorylation at Thr202/Tyr204 and protein expression,
caused by the diet or hormone treatment (Fig. 4(a) and (b)).
Discussion
Akt and eNOS play a very important role in the regulation of
cardiac functions(10,12). Cardiac Akt/eNOS signalling is a
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Fig. 2. Alterations of cardiac Akt phosphorylation at (a) Ser473 (pSer473), (b)
Thr308 (pThr308) and (c) protein expression in fructose-fed rats in the absence
or presence of oestradiol. Protein samples of the cardiac cell lysate of ovari-
ectomised female rats on the normal or fructose-enriched diet, with or without
oestradiol (E2) replacement, were analysed by the Western blot method using
an antibody against Akt or Akt phosphorylated at Ser473 or Thr308. Three
independent experiments with a total of nine rats per group were quantified.
Phospho-Akt content was normalised to total Akt. Results are expressed as a
fold of appropriate control value (ovariectomised rats on normal diet). Values
are means, with standard deviations represented by vertical bars. Representa-
tive Western blots are also shown. OVX, ovariectomy; ND, normal diet; FRD,
fructose-rich diet; INS, insulin treatment. Mean value was significantly different
from that of the OVX-ND group: *P,0·05. Mean value was significantly differ-
ent from that of the OVX-ND group: **P,0·01. Mean value was significantly
different from that of the OVX-ND group: ***P,0·001. Mean value was signifi-
cantly different from that of the OVX-ND þ INS group: ‡P,0·05. , OVX-ND;
, OVX-FRD; , OVX-FRD þ E2; , OVX-ND þ INS; , OVX-FRD þ INS; ,
OVX-FRD þ E2 þ INS.
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target of insulin resistance(6) and E2 regulation as well(16).
Phosphorylation of eNOS by Akt with a subsequent increase
in NO production is an important downstream effector in
the anti-apoptotic signalling by insulin. Moreover, increasing
evidence suggests that eNOS acts as a metabolic sensor in car-
diomyocytes, implying that defective NO production might be
linked to cardiomyocyte metabolism dysfunction(18). On the
basis of published data, we performed the study of the effects
of oestrogen replacement on this signalling pathway in ovari-
ectomised female rats fed the FRD. In addition, we analysed
heart mass and the mitogenic Erk pathway, which also might
be modulated by the diet regimen and oestrogen treatment.
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Fig. 3. Changes in the phosphorylation of endothelial nitric oxide synthase (eNOS) at (a) Ser1177 (pSer1177), (b) Thr495 (pThr495) and (c) eNOS protein expression
and (d) steady-state eNOS mRNA level in the heart of rats on the fructose-enriched diet: the role of oestradiol. Protein samples of cardiac cell lysate were
resolved on 7·5 % SDS–PAGE and analysed by the Western blot method using an antibody raised against eNOS or eNOS phosphorylated at Ser1177 or Thr495.
Three independent experiments with a total of nine rats per group were quantified. Phospho-eNOS content was normalised to total eNOS. Results are expressed
as a fold of appropriate control value (ovariectomised rats on the normal diet). Values are means, with standard deviations represented by vertical bars. Represen-
tative Western blots are also shown. OVX, ovariectomy; ND, normal diet; INS, insulin treatment; FRD, fructose-rich diet; E2, oestradiol treatment. Mean value was
significantly different from that of the OVX-ND group: *P,0·05. Mean value was significantly different from that of the OVX-ND group: ***P,0·001. Mean value
was significantly different from that of the OVX-FRD group: †P,0·05. Mean value was significantly different from that of the OVX-FRD group: †††P,0·001.
Mean value was significantly different from that of the OVX-ND þ INS group: ‡P,0·05. Mean value was significantly different from that of the OVX-FRD þ INS
group: §§P,0·01. , OVX-ND; , OVX-FRD; , OVX-FRD þ E2; , OVX-ND þ INS; , OVX-FRD þ INS; , OVX-FRD þ E2 þ INS.
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Fig. 4. Effects of the fructose-rich diet and oestradiol treatment on cardiac (a) Erk 1/2 Thr202/Tyr204 phosphorylation level and (b) Erk 1/2 protein expression.
The content of total Erk 1/2 and pThr202)/Tyr204 Erk 1/2 in the lysate of cardiac cells was analysed by Western blot using a specific antibody raised against Erk 1/2
or Erk 1/2 phosphorylated at Thr202/Tyr204. Three independent experiments with a total of nine rats per group were quantified. Phospho-Erk 1/2 content was nor-
malised to total Erk 1/2. Results are expressed as a fold of appropriate control value (ovariectomised rats on the normal diet). Values are means, with standard
deviations represented by vertical bars. Representative Western blots are also shown. OVX, ovariectomy; ND, normal diet; INS, insulin treatment; FRD, fructose-
rich diet; E2, oestradiol treatment. , OVX-ND; , OVX-FRD; , OVX-FRD þ E2; , OVX-ND þ INS; , OVX-FRD þ INS; , OVX-FRD þ E2 þ INS.
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In contrast to studies implicating fructose effects on the
development of heart hypertrophy(21–23), we did not observe
any changes in absolute and relative heart mass in FFR, which
could be attributed to the duration of the diet regimen and/or
the content of fructose in the applied diet(21,23). Hormone
replacement treatment was also ineffective in terms of the
changes in the heart mass of FFR. These data are in line
with the results obtained for the mitogenic Erk 1/2 signalling
pathway regulating cell proliferation and growth, where
diet- or hormone-related changes were absent. The lack of
the fructose effect on Erk 1/2 phosphorylation is in accord-
ance with our recently reported results(6), but the absence
of the E2 effect is in contrast to the results obtained in cell
culture(24) or in acute hormone treatment(25). It could be a
consequence of the way of hormone administration, but also
might implicate some fructose diet-induced disturbances in
the activation of Erk 1/2 signalling by E2.
The results of the present study concerning the deregulation
of cardiac Akt/eNOS signalling in FFR are mostly in accord-
ance with literature data. As we already reported, the fruc-
tose-enriched diet decreased cardiac Akt phosphorylation at
Ser473 and Thr308 and eNOS at Ser1177, especially in insulin-
stimulated conditions(6). On the other hand, increased intake
of fructose stimulated inhibitory phosphorylation of cardiac
eNOS at threonine 495. It was well documented that heart
eNOS activity is decreased in FFR(5,22,37,38). Myocardial Akt
protein expression and its Ser473 phosphorylation, as well as
eNOS expression and phosphorylation at Ser1177, were
decreased in FFR(39). However, in contrast to the present
results, expression of eNOS protein and mRNA was shown
to be reduced in the heart of FFR(40). It was astounding that
we observed no effect of the fructose diet on eNOS protein
content, but a strong increase in the gene expression. We
have no physiological explanation particularly regarding that
OVX and fructose, in the present study, separately caused a
strong decrease in cardiac eNOS mRNA level.
There are no published data concerning the effects of E2
on cardiac Akt/eNOS signalling in increased fructose intake
conditions or other animal models of insulin resistance. The
only relevant results that can be cited are those describing
the effects of E2 treatment in normal rats. We recently reported
a rapid stimulatory effect of a single injection of E2 on cardiac
Akt Ser473 and Thr308, as well as on eNOS Ser1177 phosphoryl-
ation(41). Others have also observed that E2 treatment
increased Akt phosphorylation and Akt-mediated eNOS phos-
phorylation (Ser1177)(42). A number of studies have shown that
E2 increased cardiac levels of eNOS, and phosphorylated
eNOS (Ser1177), thus exerting potentially beneficial cardio-
vascular effects of NO(43,44). In ovariectomised rats, E2
replacement restored eNOS activity and expression(45). E2
stimulated the expression of eNOS in both neonatal and
adult cardiac myocytes(15). In the present study, we observed
no effect of E2 on the expression of eNOS in the heart of FFR
and its threonine 495 phosphorylation, while the hormone
effect on serine 1177 phosphorylation was strongly inducible.
We noted that the effect of the FRD and the ability of E2 to
exert an effect on phosphorylation of different amino acid
residues in Akt and eNOS are selective. Observed differences
in the effects of fructose and E2 on the phosphorylation level
of different amino acids in the protein structure of Akt and
eNOS actually implicate the different effects of these agents
on kinase/phosphatase pathways responsible for the phos-
phorylation/dephosphorylation of these sites. It is well
known that phosphorylation of Akt Thr308 is attributed to
phosphoinositide-dependent protein kinase 1 (PKD1) kinase,
while Rictor-mammalian target of repamycin (mTOR) kinase
is probably responsible for Ser473 phosphorylation(19). On
the other hand, eNOS is a substrate of Akt kinase that phos-
phorylates the Ser1177 position(46). The phosphatase to which
is referred insulin-induced dephosphorylation of eNOS at
the negative regulatory site Thr495 is probably protein phos-
phatase 1(20).
To the best of our knowledge, no published literature con-
tains any data concerning the effects of enhanced fructose
intake on kinases/phosphatases involved in the phosphoryl-
ation/dephosphorylation of Akt and eNOS molecules on
amino acid residues analysed in the present study, except
Akt as a kinase responsible for eNOS phosphorylation at
Ser1177. The FRD-induced decrease in Akt phosphorylation
points to the decreased activity of responsible kinases or the
increased activity of phosphatases that counteract PDK1 and
Rictor-mTOR. Inhibition of Akt could be a direct explanation
of the observed decrease in the phosphorylation of eNOS at
Ser1177 in FFR. The increase in the phosphorylation of eNOS
at Thr495 in animals fed on the FRD indicates changes in the
activity of protein phosphatase 1 or kinases responsible for
the phosphorylation of this amino acid residue.
Data concerning the effects of E2 on these kinases and
phosphatases, particularly in cardiac tissue, are also extremely
scarce and we can only speculate, on the basis of the present
results, that E2 activates cardiac Rictor-mTOR kinase and
probably PDK1, but has no effect on protein phosphatase 1
in the heart.
In conclusion, there was a consistent suppression of cardiac
Akt/eNOS signalling at the level of protein phosphorylation in
FFR. It is interesting to note that E2 managed to abrogate
some, but not all, of fructose-induced damage at the basal
level or in insulin-stimulated conditions, implicating its selec-
tive effects on kinase and phosphatase pathways involved in
the activation of Akt/eNOS signalling. As a matter of future
perspectives, it would be very intriguing to conduct an
additional study the effects of E2 on PDK1, Rictor-mTOR
and protein phosphatase 1 in cardiac tissue.
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